-
公开(公告)号：US20070202167A1
公开(公告)日：2007-08-30
申请号：US10879506
申请日：2004-06-30
申请人： Viswanathan Srinivasan , Ralph Brown , David Brown , Himanshu Patel , Juan Menendez , Sornphet Suphasawud
发明人： Viswanathan Srinivasan , Ralph Brown , David Brown , Himanshu Patel , Juan Menendez , Sornphet Suphasawud
CPC分类号： A61K31/439 , A61K9/0095 , A61K9/209 , A61K31/46
摘要： A pharmaceutical dosage form which comprises two or more different hyoscyamine formulations, at least one of the formulations being an immediate release hyoscyamine formulation and at least one other one being a controlled release hyoscyamine formulation. This abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.
摘要翻译： 一种药物剂型，其包含两种或更多种不同的莨菪碱制剂，所述制剂中的至少一种是立即释放的莨菪碱制剂，并且至少一种其它制剂是受控释放的莨菪碱制剂。 该摘要既不旨在限定本说明书中公开的发明，也不旨在以任何方式限制本发明的范围。
-
公开(公告)号：US20050232987A1
公开(公告)日：2005-10-20
申请号：US10798884
申请日：2004-03-12
申请人： Viswanathan Srinivasan , Ralph Brown , David Brown , Himanshu Patel , Juan Menendez , Venkatesh Balasubramanian
发明人： Viswanathan Srinivasan , Ralph Brown , David Brown , Himanshu Patel , Juan Menendez , Venkatesh Balasubramanian
IPC分类号： A61K9/00 , A61K9/20 , A61K9/24 , A61K31/137 , A61K31/485
CPC分类号： A61K9/2077 , A61K9/209 , A61K31/137 , A61K31/485 , A61K2300/00
摘要： A pharmaceutical dosage form which comprises a first drug which comprises at least one morphine derivative with antitussive activity and at least one second drug. The dosage form provides a plasma concentration within the therapeutic range of the at least one second drug over a period which is coextensive with at least about 70% of the period over which the dosage form provides a plasma concentration within the therapeutic range of the first drug. This abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.
摘要翻译： 一种药物剂型，其包含含有至少一种具有镇咳活性的吗啡衍生物和至少一种第二药物的第一药物。 所述剂型在所述至少一种第二药物的治疗范围内提供血浆浓度，所述时间段与至少约70％的所述时间段共同延长的时间段内，所述剂型在该时间段内提供在第一药物的治疗范围内的血浆浓度 。 该摘要既不旨在限定本说明书中公开的发明，也不旨在以任何方式限制本发明的范围。
-
公开(公告)号：US20050266032A1
公开(公告)日：2005-12-01
申请号：US11115321
申请日：2005-04-27
申请人： Viswanathan Srinivasan , Ralph Brown , David Brown , Himanshu Patel , Juan Menendez , Venkatesh Balasubramanian , Somphet Suphasawud
发明人： Viswanathan Srinivasan , Ralph Brown , David Brown , Himanshu Patel , Juan Menendez , Venkatesh Balasubramanian , Somphet Suphasawud
IPC分类号： A61K31/137 , A61K31/485
CPC分类号： A61K45/06 , A61K31/137 , A61K31/485 , A61K2300/00
摘要： A pharmaceutical dosage form comprising a first drug and a second drug, both of which are selected from decongestants, antitussives, expectorants, analgesics and antihistamines. The dosage form provides a plasma concentration within a therapeutic range of the second drug over a period which is coextensive with at least about 70% of a period over which the dosage form provides a plasma concentration within a therapeutic range of the first drug. This Abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.
摘要翻译： 一种包含第一药物和第二药物的药物剂型，它们都选自减充血剂，镇咳药，祛痰剂，止痛剂和抗组胺剂。 剂型提供在第二药物的治疗范围内的血浆浓度，其在与第一药物的治疗范围内提供血浆浓度的至少约70％的期间共同延长的时期内。 本摘要既不旨在限定本说明书中公开的发明，也不旨在以任何方式限制本发明的范围。
-
公开(公告)号：US09308164B2
公开(公告)日：2016-04-12
申请号：US10879506
申请日：2004-06-30
申请人： Viswanathan Srinivasan , Ralph Brown , David Brown , Himanshu Patel , Juan Carlos Menendez , Somphet Peter Suphasawud
发明人： Viswanathan Srinivasan , Ralph Brown , David Brown , Himanshu Patel , Juan Carlos Menendez , Somphet Peter Suphasawud
CPC分类号： A61K31/439 , A61K9/0095 , A61K9/209 , A61K31/46
摘要： A pharmaceutical dosage form which comprises two or more different hyoscyamine formulations, at least one of the formulations being an immediate release hyoscyamine formulation and at least one other one being a controlled release hyoscyamine formulation. This abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.
摘要翻译： 一种药物剂型，其包含两种或更多种不同的莨菪碱制剂，所述制剂中的至少一种是立即释放的莨菪碱制剂，并且至少一种其它制剂是受控释放的莨菪碱制剂。 该摘要既不旨在限定本说明书中公开的发明，也不旨在以任何方式限制本发明的范围。
-
公开(公告)号：US20050232986A1
公开(公告)日：2005-10-20
申请号：US10736902
申请日：2003-12-17
IPC分类号： A61K9/20 , A61K9/24 , A61K31/192 , A61K31/485 , A61K31/5415 , A61K31/60 , A61K45/06
CPC分类号： A61K9/209 , A61K9/2077 , A61K31/485 , A61K31/5415 , A61K45/06 , A61K2300/00
摘要： A pharmaceutical dosage form which comprises promethazine and/or a pharmaceutically acceptable salt thereof and at least one second drug. The dosage form provides a plasma concentration within the therapeutic range of the at least one second drug over a period which is coextensive with a substantial part of the period over which the dosage form provides a plasma concentration within the therapeutic range of promethazine or salt thereof. This abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.
摘要翻译： 包含异丙嗪和/或其药学上可接受的盐和至少一种第二种药物的药物剂型。 所述剂型在所述至少一种第二药物的治疗范围内提供血浆浓度，所述血浆浓度在与所述剂型在异丙嗪或其盐的治疗范围内提供血浆浓度的相当长的一段时间内共同延长的时期内。 该摘要既不旨在限定本说明书中公开的发明，也不旨在以任何方式限制本发明的范围。
-
公开(公告)号：US20050281875A1
公开(公告)日：2005-12-22
申请号：US11102725
申请日：2005-04-11
IPC分类号： A61K9/20 , A61K9/24 , A61K31/192 , A61K31/485 , A61K31/5415 , A61K31/60 , A61K45/06
CPC分类号： A61K9/2077 , A61K9/2027 , A61K9/2086 , A61K9/209 , A61K31/485 , A61K31/5415 , A61K45/06 , A61K2300/00
摘要： A pharmaceutical dosage form which comprises promethazine and/or a pharmaceutically acceptable salt thereof. The dosage form is capable of providing a promethazine plasma concentration within a therapeutic range for at least about 24 hours per single dose. This Abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.
摘要翻译： 包含异丙嗪和/或其药学上可接受的盐的药物剂型。 该剂型能够在治疗范围内提供每一剂量至少约24小时的异丙嗪血浆浓度。 本摘要既不旨在限定本说明书中公开的发明，也不旨在以任何方式限制本发明的范围。
-
公开(公告)号：US20050232993A1
公开(公告)日：2005-10-20
申请号：US11115293
申请日：2005-04-27
IPC分类号： A61K9/20 , A61K9/24 , A61K31/192 , A61K31/485 , A61K31/5415 , A61K31/60 , A61K45/06
CPC分类号： A61K9/209 , A61K9/2077 , A61K31/485 , A61K31/5415 , A61K45/06 , A61K2300/00
摘要： A pharmaceutical dosage form which comprises promethazine and/or a pharmaceutically acceptable salt thereof and at least one second drug. The dosage form provides a plasma concentration within the therapeutic range of the at least one second drug over a period which is coextensive with a substantial part of the period over which the dosage form provides a plasma concentration within the therapeutic range of promethazine or salt thereof. This Abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.
摘要翻译： 包含异丙嗪和/或其药学上可接受的盐和至少一种第二种药物的药物剂型。 所述剂型在所述至少一种第二药物的治疗范围内提供血浆浓度，所述血浆浓度在与所述剂型在异丙嗪或其盐的治疗范围内提供血浆浓度的相当长的一段时间内共同延长的时期内。 本摘要既不旨在限定本说明书中公开的发明，也不旨在以任何方式限制本发明的范围。
-
公开(公告)号：US08574216B2
公开(公告)日：2013-11-05
申请号：US13339316
申请日：2011-12-28
申请人： Emilian Istoc , Himanshu Patel
发明人： Emilian Istoc , Himanshu Patel
IPC分类号： A61M31/00
CPC分类号： A61M5/1723 , A61M5/1413 , A61M5/142 , A61M5/14244 , A61M5/16804 , A61M5/172 , A61M2205/3553 , A61M2205/3569 , A61M2205/3584 , A61M2205/3592 , A61M2205/52 , A61M2230/201
摘要： A modular external infusion device that controls the rate a fluid is infused into an individual's body, which includes a first module and a second module. More particularly, the first module may be a pumping module that delivers a fluid, such as a medication, to a patient while the second module may be a programming module that allows a user to select pump flow commands. The second module is removably attachable to the first module.
-
公开(公告)号：US08414557B2
公开(公告)日：2013-04-09
申请号：US13450293
申请日：2012-04-18
申请人： Emilian Istoc , Himanshu Patel
发明人： Emilian Istoc , Himanshu Patel
IPC分类号： A61M31/00
CPC分类号： A61M5/1723 , A61M5/1413 , A61M5/142 , A61M5/14244 , A61M5/16804 , A61M5/172 , A61M2205/3553 , A61M2205/3569 , A61M2205/3584 , A61M2205/3592 , A61M2205/52 , A61M2230/201
摘要： A modular external infusion device that controls the rate a fluid is infused into an individual's body, which includes a first module and a second module. More particularly, the first module may be a pumping module that delivers a fluid, such as a medication, to a patient while the second module may be a programming module that allows a user to select pump flow commands. The second module is removably attachable to the first module.
-
公开(公告)号：US20120150007A1
公开(公告)日：2012-06-14
申请号：US13397991
申请日：2012-02-16
申请人： EMILIAN ISTOC , Himanshu Patel
发明人： EMILIAN ISTOC , Himanshu Patel
CPC分类号： A61M5/1723 , A61M5/1413 , A61M5/142 , A61M5/14244 , A61M5/16804 , A61M5/172 , A61M2205/3553 , A61M2205/3569 , A61M2205/3584 , A61M2205/3592 , A61M2205/52 , A61M2230/201
摘要： A modular external infusion device that controls the rate a fluid is infused into an individual's body, which includes a first module and a second module. More particularly, the first module may be a pumping module that delivers a fluid, such as a medication, to a patient while the second module may be a programming module that allows a user to select pump flow commands. The second module is removably attachable to the first module.
-
-
-
-
-
-
-
-
-
搜索结果
65 条记录 (耗时 0.026 秒)